Dr Elin Haf Davies CEO of Aparito

Dr. Elin Haf Davies

Dr Elin Haf Davies is the CEO & Founder of Aparito.

Dr Elin Haf Davies founded Aparito in 2014 on the back of 21 years of clinical (as Senior Clinical Research Nurse and Trial Administrator, Great Ormond Street Children’s Hospital, London), research (PhD, University College London, UK) and regulatory experience (as Scientific Assessor at both the Medicines Health Regulatory Authority (MHRA) and the European Medicine Agency (EMA)).

At the EMA Elin Haf was part of the core team responsible for implementing the E.U. Paediatric Regulation which came into force in January 2007.

Elin continues to be involved in the research and development of new and emerging drug treatments for rare diseases in children. Her PhD – focusing on developing new outcome measures for gait and ataxia in children with neuro-Lysosomal Storage Disorders resulted in many peer-reviewed journals. Since 2013, Elin Haf has been an Associate Fellow at the Centre for the Advancement of Sustainable Medical Innovation (CASMI) and an Academic Fellow at Bangor University since 2014 dedicated to the cost evaluation of orphan drugs.

Her considerable career in clinical, academic and regulatory fields, combined with extensive dialogue and collaboration with patient groups, means that she brings innovation and designs as a solution to all stakeholder groups. Elin’s passion has always been to inspire children, especially those with chronic illnesses, to be empowered and engaged in their own lives.

Aparito was founded as a tech solution to contribute to patient empowerment in the drug development pathway and completely transform the way clinical studies are conducted and novel eCOA are developed.

In addition to her work at Aparito, Elin is the Chair of Metabolic Support UK, the leading patient organisation for Inherited Metabolic Disorders supporting thousands of patients worldwide.

Ready to get started?

Share your study requirements and unlock the potential of Atom5™ for your clinical trial!

Read More
Dr Rashmi Narayana Chief Scientific Officer at Aparito

Dr Rashmi Narayana

 Dr Rashmi Narayana is the Chief Scientific Officer at Aparito

Rashmi qualified as a psychiatrist and made her way to healthtech via leadership roles at the American Red Cross, academia, and research management. She has held roles as Clinical Director at uMotif,  as Head of Clinical Development and Head of Clinical and Regulatory Affairs at Huma and, as Director of Operations at Our Mobile Health.

She has numerous peer-reviewed publications to her name. She holds a Masters in Public Health from the London School of Hygiene and Tropical Medicine and an MBA from Imperial College Business School, London.  Over the pandemic, she trained and certified as a leadership coach.  

Ready to get started?

Share your study requirements and unlock the potential of Atom5™ for your clinical trial!

Read More

Chris Frost

Chris Frost is the Chief Operations Officer at Aparito.

Chris is responsible for delivering Aparito’s objectives and the continuous evolution of our flagship product, Atom5TM.

Chris has a passion for developing innovative digital outcome measures and as such has been responsible for the delivery of over 1000 eCOA tools and co-authored several papers during his time at Aparito.

Ready to get started?

Share your study requirements and unlock the potential of Atom5™ for your clinical trial!

Read More

Aleksa Vukotic

Aleksa Vukotic is Chief Technology Officer at Aparito.

Aleksa Vukotic leads the Aparito technology team and is responsible for the technology vision and design of the Atom5™ platform. As an experienced technologist and expert in cloud-native microservices architectures and API design Aleksa has a track record as a technology leader, speaker and author within the scope of Open Source, DevOps and BigData/NoSQL technologies across finance, lifestyle and health sectors. 

Aleksa is a published author (Neo4j in Action, published by Manning; and Pro Spring 2.5 and Apache Tomcat 7, both published by Apress), and in addition to regularly speaking at technology conferences and meetups, he is an active member of the UK tech startup scene.

Ready to get started?

Share your study requirements and unlock the potential of Atom5™ for your clinical trial!

Read More

Dr Graciëlle Schutjens

Dr Graciëlle Schutjens is Scientific Business Advisor and Director of Aparito B.V.

Graciëlle joined Aparito following a distinguished career starting as a Clinical Research Project Manager with Quintiles (now IQVIA) before her passion for education and training saw her promoted to Training and Quality Control Manager for Europe at Parexel.

Graciëlle’s love for developing young CRAs led to her forming her CRO in 2000 which she sold to Venn Life Sciences in 2010 where she stayed on as Chief Operating Officer to oversee an AIM listing and growth through M&A with companies throughout the UK and Europe before leaving in 2018 to work as a freelance consultant.

Ready to get started?

Share your study requirements and unlock the potential of Atom5™ for your clinical trial!

Read More
Dr Elisa Ferrer Mallol

Dr Elisa Ferrer Mallol

Dr Elisa Ferrer Mallol is the Patient Advocacy Manager at Aparito.

Elisa holds a Pharmacy degree and a PhD in physiology. She has broad experience in different areas of the healthcare industry, such as drug safety, medical publishing and research project management.

In the last few years, she worked in the rare disease patient advocacy space, first at EURORDIS, the European umbrella of rare disease patient organisations, and now at Aparito, managing the Patient Group Accelerator, a programme to help co-design digital endpoints in partnership with patient groups.

Ready to get started?

Share your study requirements and unlock the potential of Atom5™ for your clinical trial!

Read More